
“Supports microbiota balance” has become a line you read everywhere and that says almost nothing. Balance between what? Measured how? The interesting question is not whether an ingredient may say it, but what it takes to demonstrate it.
Microbiota is not one thing: it differs by district — gastrointestinal, urogenital, oral — and within each district the microbial community has different balances. An ingredient that favours a useful genus in the gut does not automatically do the same in the mouth. Saying “balance” without saying where and against which microorganisms leaves the claim indefensible.
Selective growth. This is the core of the prebiotic assay: you check whether the ingredient favours the growth of beneficial microorganisms without favouring the undesirable ones to the same extent. What counts is the comparison, not absolute growth.
Antimicrobial selectivity. The other side of the coin: inhibiting problem microorganisms while leaving the others alone. It is a harder ask than generic antimicrobial activity, and far more credible.
The right district. A gastrointestinal, a urogenital and an oral model start from different microbial communities and respond differently. The model is chosen against the claim, not from the catalogue.
What happens to the host. Barrier integrity, inflammatory response, adhesion: the effect on microbiota becomes interesting when you can also see it from the human cell side.
A serious prebiotic assay needs more conditions and more replicates than a simple growth test, because the signal is a ratio between populations rather than a single number. Biological variability is high and has to be handled through experimental design, not explained afterwards. And the result is specific to the district and to the formulation tested: it does not transfer to another product by analogy.
Which district do you want to speak about, and does your product actually reach it? Against which microorganisms do you define “balance”? Does the claim concern the ingredient or the finished formulation, which is what the consumer uses? And will the data you obtain survive a regulator’s question, or does it only serve to tell a story?
With targeted assays that quantify the selective growth of beneficial versus undesirable microorganisms, on models of the relevant district, paired where needed with cellular and tissue models showing the effect on the host: barrier integrity, inflammatory response, adhesion. Precision here does not only strengthen a claim: it makes it believable.
If you work on probiotics, postbiotics or functional fibres, the gastrointestinal area page collects the models we use; for an ingredient still to be characterised, start from ingredient validation.
Technical content and news from our laboratories, sent when there is something worth saying.